F.Biotechnology Dis.Fd.N-H1 PLN
LU2251237215
F.Biotechnology Dis.Fd.N-H1 PLN/ LU2251237215 /
| NAV14/05/2024 |
Var.+0.0500 |
Type of yield |
Focus sugli investimenti |
Società d'investimento |
| 9.6900PLN |
+0.52% |
reinvestment |
Equity
Worldwide
|
Franklin Templeton ▶ |
Investment goal
The Fund aims to capital appreciation by investing principally in equity securities of biotechnology companies and discovery research firms mainly located in the US.
Dati master
| Type of yield: |
reinvestment |
| Fondi Categoria: |
Equity |
| Region: |
Worldwide |
| Settore: |
Sector Biotechnology |
| Benchmark: |
NASDAQ Biotechnology Index |
| Business year start: |
01/07 |
| Ultima distribuzione: |
- |
| Banca depositaria: |
J.P. Morgan SE, Niederlassung Luxemburg |
| Domicilio del fondo: |
Luxembourg |
| Permesso di distribuzione: |
Austria, Germany, Switzerland |
| Gestore del fondo: |
Evan McCulloch, Wendy Lam, Akiva Felt |
| Volume del fondo: |
1.63 bill.
USD
|
| Data di lancio: |
12/11/2020 |
| Investment focus: |
- |
Condizioni
| Sovrapprezzo emissione: |
3.00% |
| Tassa amministrativa massima: |
2.25% |
| Investimento minimo: |
1,000.00 PLN |
| Deposit fees: |
0.14% |
| Redemption charge: |
0.00% |
| Prospetto semplificato: |
Download (Print version) |
Società d'investimento
| Funds company: |
Franklin Templeton |
| Indirizzo: |
Schottenring 16, 2.OG, 1010, Wien |
| Paese: |
Austria |
| Internet: |
www.franklintempleton.at
|
Attività
| Stocks |
|
92.46% |
| Bonds |
|
1.90% |
| Altri |
|
5.64% |
Paesi
| United States of America |
|
76.14% |
| Netherlands |
|
4.51% |
| United Kingdom |
|
4.08% |
| Denmark |
|
4.03% |
| Ireland |
|
2.67% |
| France |
|
1.10% |
| Cayman Islands |
|
0.52% |
| Canada |
|
0.50% |
| Bermuda |
|
0.45% |
| Germany |
|
0.36% |
| Altri |
|
5.64% |
Filiali
| Pharma/Biotechnology |
|
87.69% |
| Healthcare services |
|
4.41% |
| Healthcare appliances |
|
0.36% |
| Altri |
|
7.54% |
